NCT00141765
- Conditions
- Brain Diseases, Brain Neoplasms, Brain Tumor, Recurrent, +38 more
- Locations
-
- The University of Michigan Ann Arbor, Michigan, United States
Clinical trial condition
Wilms Tumor
Explore clinical trials studying Wilms Tumor. Study availability and eligibility vary by location and protocol.
57 public trials
14 recruiting studies
Wilms Tumor trial results
NCT01095926
- Conditions
- Acute Lymphoblastic Leukemia, Cardiotoxicity, Cardiovascular Diseases, +44 more
- Locations
-
- Centre Oscar Lambret Lille, France
- CHU La Timone Marseille, France
- MD Nicolas Andre, National Study Manager France Marseille, France
- CHU Nancy Nancy, France
NCT00436657
- Conditions
- Abdominal Neoplasms, Adenocarcinoma, Adnexal Diseases, +52 more
- Locations
-
- UT MD Anderson Cancer Center Houston, Texas, United States
NCT00152126
- Conditions
- Central Nervous System Neoplasms, Central Nervous System Tumors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +33 more
- Locations
-
- St. Jude Children's Research Hospital Memphis, Tennessee, United States
NCT00336531
- Conditions
- Bacterial Infections and Mycoses, Brain Diseases, Brain Neoplasms, +38 more
- Locations
-
- Samsung Medical Center Seoul, South Korea
NCT00187031
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +14 more
- Locations
-
- Children's Healthcare Atlanta, Georgia, United States
- Dana Farber Boston, Massachusetts, United States
- St. Jude Children's Research Hospital Memphis, Tennessee, United States
- Baylor College of Medicine Houston, Texas, United States
NCT03155620
- Conditions
- Advanced Malignant Solid Neoplasm, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma, +99 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- Banner Children's at Desert Mesa, Arizona, United States
- Phoenix Childrens Hospital Phoenix, Arizona, United States
Active, Not Recruiting
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
NCT02867592
- Conditions
- Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +92 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- Arkansas Children's Hospital Little Rock, Arkansas, United States
- Kaiser Permanente-Anaheim Anaheim, California, United States
Active, Not Recruiting
Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)
NCT03213652
- Conditions
- Advanced Malignant Solid Neoplasm, Central Nervous System Neoplasms, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +82 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- Banner Children's at Desert Mesa, Arizona, United States
- Banner University Medical Center - Tucson Tucson, Arizona, United States
Active, Not Recruiting
Ivosidenib in Treating Patients With Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With IDH1 Mutations (A Pediatric MATCH Treatment Trial)
NCT04195555
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Ependymoma, Female Urogenital Diseases, +80 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- Banner Children's at Desert Mesa, Arizona, United States
- Phoenix Childrens Hospital Phoenix, Arizona, United States